1. Home
  2. CTNT vs SNOA Comparison

CTNT vs SNOA Comparison

Compare CTNT & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

N/A

Current Price

$1.48

Market Cap

5.4M

Sector

N/A

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$2.45

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
SNOA
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
6.1M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
CTNT
SNOA
Price
$1.48
$2.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.4K
10.9K
Earning Date
05-04-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$455,805.00
$14,288,000.00
Revenue This Year
$235.67
$23.00
Revenue Next Year
$20.00
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.19
52 Week Low
$1.03
$1.77
52 Week High
$2.12
$6.92

Technical Indicators

Market Signals
Indicator
CTNT
SNOA
Relative Strength Index (RSI) 49.26 37.36
Support Level $1.36 $2.30
Resistance Level $1.50 $3.85
Average True Range (ATR) 0.15 0.18
MACD -0.03 0.00
Stochastic Oscillator 12.33 19.61

Price Performance

Historical Comparison
CTNT
SNOA

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: cargo storage, freight forwarding, U.S. customs clearance, and (iv) labor services and cargo loading and unloading.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: